Article Sidebar

Download
Requires Subscription PDF
Statistic
Read Counter : 412 Download : 5

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Main Article Content

Abstract

MASC (Mammary Analogue Secretory Carcinoma) is a recently recognized tumor of salivary glands with morphological, immunohistochemical and molecular characteristics similar to secretory carcinoma of the breast. Case report: A 49-year-old male presented with a painless mass in the right parotid region. On FNAC, it was reported as a Warthin tumor. Superficial parotidectomy was done and sent for histopathological examination, where it was reported as MASC.


MASC of salivary glands was first described by Skalova et al., in 2010.[1] Skálová et al looked into a variety of salivary gland cancers and found that while MASC and acinar cell carcinoma share similarities, they are distinct entities with different histological features.[1] Because of the tumor's remarkable morphologic, immunohistochemical, and molecular resemblance to breast secretory carcinoma, it was given that name.[2] It has been demonstrated that a recurring balanced chromosomal translocation t (12;15) (p13; q25) in secretory carcinoma of the breast results in an oncogenic fusion gene ETV6-NTRK3. In MASC, this translocation is also found.[3] A chimeric tyrosine kinase that is encoded by this fusion gene is known to be crucial to its carcinogenesis.[4] MASC and breast SC share immunohistochemical characteristics, such as having S100 protein, EMA (Epithelial Membrane Antigen), vimentin positive, and being "triple negative" (ER/PR/Her2 negative).[5]


The parotid gland is the primary site of MASC, a rare malignant tumor of the salivary glands, which is followed by the submandibular gland, minor salivary gland, and accessory parotid gland.[6,7] Men are most frequently affected by MASC, and they typically do not act aggressively.[8] A slowly expanding solid mass and the absence of pain are the clinical signs of MASC. Due to the relatively low imaging specificities and clinical characteristics, the tumor could be misdiagnosed.[9]


Here we describe mammary analogue secretory carcinoma in a 49-year-old male.

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite
Sandhya M., Vaishnavi M. S., Sowmya T. S., & Purushotham Ramaiah. (2025). A Parotid Puzzle - Mammary Analogue Secretory Carcinoma in Parotid Gland. Journal of Evolution of Medical and Dental Sciences, 14(3), 69–72. https://doi.org/10.14260/jemds.v14i3.762
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010;34:599-608. DOI: https://doi.org/10.1097/PAS.0b013e3181d9efcc
  2. Din N, Fatima S, Kayani N. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic study of 11 cases. Ann Diagn Pathol 2016;22:49-53. DOI: https://doi.org/10.1016/j.anndiagpath.2016.04.003
  3. Bishop J, Yonescu R, Bastista D, et al. Most nonparotid actinic cell carcinomas represent mammary analog secretory carcinomas. Am J Surg Pathol 2013;37:1053-7. DOI: https://doi.org/10.1097/PAS.0b013e3182841554
  4. Majewska H, Skálová A, Stodulski D, et al. Mammary analogue secretorycarcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch 2015;466(3):245-54. DOI: https://doi.org/10.1007/s00428-014-1701-8
  5. Connor A, Perez-Ordoñez B, Shago M, et al. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 2012;36(1):27-34.
  6. Khalele BA. Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description. Head Neck 2017;39:1243-8. DOI: https://doi.org/10.1002/hed.24755
  7. Hindocha N, Wilson MH, Pring M, et al. Mammary analogue secretory carcinoma of the salivary glands: a diagnostic dilemma. Br J Oral Maxillofac Surg 2017;55:290-2. DOI: https://doi.org/10.1016/j.bjoms.2016.07.029
  8. Levine P, Fried K, Krevitt L, et al. Aspiration biopsy of mammary analogue secretory carcinoma of accessory parotid gland: another diagnostic dilemma in matrix-containing tumors of the salivary glands, DiagnCitopathol2012;42:49-53. DOI: https://doi.org/10.1002/dc.22886
  9. Skalova A, Michal M, Simpson RH. Newly described salivary gland tumors. Mod Pathol2017;30:S27-43. DOI: https://doi.org/10.1038/modpathol.2016.167
  10. Balanzáa R, Arrangoizb R, Corderab F, et al. Mammary analog secretory carcinoma of the parotid gland: a case report and literature review. International Journal of Surgery Case Reports 2015;16:187-91. DOI: https://doi.org/10.1016/j.ijscr.2015.09.031
  11. Gaopande VL, Kulkarni MM, Khandeparkar SG, et al. Mammary analog secretory carcinoma parotid gland: Case report of a recently described tumor with review of literature. Asian J Oncol 2017;3:139‑43. DOI: https://doi.org/10.4103/ASJO.ASJO_61_16
  12. Balakrishnan M, George SA, Haji BE, et al. Fine-needle aspiration cytology of mammary analog secretory carcinoma of the parotid gland: a diagnostic conundrum. J Cytol 2019;36:215-6. DOI: https://doi.org/10.4103/JOC.JOC_28_19
  13. Samulski TD, LiVolsi VA, Baloch Z. The cytopathologic features of mammary analog secretory carcinoma and its mimics. Cytojournal 2014;11:24. DOI: https://doi.org/10.4103/1742-6413.139726
  14. Stevens TM, Kovalovsky AO, Velosa C, et al. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study. Mod Pathol 2015;28:1084-100. DOI: https://doi.org/10.1038/modpathol.2015.64
  15. Skalova A. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head and Neck Pathol 2013;7:S30-6. DOI: https://doi.org/10.1007/s12105-013-0455-y
  16. Chiosea SI, Griffith C, Assaad A, et al. Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology 2012;61:387-94. DOI: https://doi.org/10.1111/j.1365-2559.2012.04232.x
  17. Connor A, Perez-Ordoñez B, Shago M, et al. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol 2012;36:27-34. DOI: https://doi.org/10.1097/PAS.0b013e318231542a
  18. Min FH, Li J, Tao BQ, et al. Parotid mammary analogue secretory carcinoma: a case report and review of literature. World J Clin Cases 2021;9(16):4052-62. DOI: https://doi.org/10.12998/wjcc.v9.i16.4052